Grant E. Blouse

623 total citations
29 papers, 522 citations indexed

About

Grant E. Blouse is a scholar working on Hematology, Cancer Research and Genetics. According to data from OpenAlex, Grant E. Blouse has authored 29 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 17 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Grant E. Blouse's work include Protease and Inhibitor Mechanisms (17 papers), Blood Coagulation and Thrombosis Mechanisms (15 papers) and Hemophilia Treatment and Research (7 papers). Grant E. Blouse is often cited by papers focused on Protease and Inhibitor Mechanisms (17 papers), Blood Coagulation and Thrombosis Mechanisms (15 papers) and Hemophilia Treatment and Research (7 papers). Grant E. Blouse collaborates with scholars based in United States, Denmark and Belgium. Grant E. Blouse's co-authors include Joseph D. Shore, Peter A. Andreasen, John Anagli, Anni Christensen, Cynthia B. Peterson, Michel Perron, Jan K. Jensen, Troels Wind, Kenneth H. Minor and Lisa Mathiasen and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

Grant E. Blouse

27 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grant E. Blouse United States 15 299 226 189 86 77 29 522
Tamar Kreizman Israel 9 212 0.7× 186 0.8× 85 0.4× 45 0.5× 28 0.4× 11 434
George A. Ward United Kingdom 14 216 0.7× 512 2.3× 100 0.5× 199 2.3× 58 0.8× 30 894
Umberto Restuccia Italy 11 144 0.5× 417 1.8× 63 0.3× 131 1.5× 68 0.9× 14 677
Shalini Iyer United Kingdom 14 181 0.6× 480 2.1× 44 0.2× 179 2.1× 57 0.7× 24 760
Tom Crabbe United Kingdom 10 153 0.5× 305 1.3× 56 0.3× 160 1.9× 93 1.2× 13 632
Erica Wilson United Kingdom 13 73 0.2× 318 1.4× 128 0.7× 159 1.8× 76 1.0× 19 729
Moon Gyo Kim South Korea 12 75 0.3× 247 1.1× 53 0.3× 87 1.0× 94 1.2× 23 442
Charlotte Boys United Kingdom 10 59 0.2× 320 1.4× 232 1.2× 77 0.9× 41 0.5× 15 657
Joseph P. Meara United States 6 167 0.6× 186 0.8× 34 0.2× 69 0.8× 38 0.5× 9 396

Countries citing papers authored by Grant E. Blouse

Since Specialization
Citations

This map shows the geographic impact of Grant E. Blouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant E. Blouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant E. Blouse more than expected).

Fields of papers citing papers by Grant E. Blouse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant E. Blouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant E. Blouse. The network helps show where Grant E. Blouse may publish in the future.

Co-authorship network of co-authors of Grant E. Blouse

This figure shows the co-authorship network connecting the top 25 collaborators of Grant E. Blouse. A scholar is included among the top collaborators of Grant E. Blouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant E. Blouse. Grant E. Blouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nyberg, Joakim, et al.. (2024). Subcutaneous Marzeptacog Alfa (Activated) for On‐Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors. Clinical Pharmacology & Therapeutics. 115(3). 498–505. 1 indexed citations
2.
Pekrun, Katja, Adriana Gonzalez‐Sandoval, Feijie Zhang, et al.. (2024). Correlation of antigen expression with epigenetic modifications after rAAV delivery of a human factor IX variant in mice and rhesus macaques. Molecular Therapy. 32(7). 2064–2079. 3 indexed citations
3.
Wijk, Rob C. van, et al.. (2023). Model‐informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy. CPT Pharmacometrics & Systems Pharmacology. 12(7). 977–987. 4 indexed citations
5.
Blouse, Grant E., et al.. (2022). Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug. CPT Pharmacometrics & Systems Pharmacology. 11(12). 1628–1637. 6 indexed citations
6.
Nair, Nisha, et al.. (2021). Gene therapy for hemophilia B using CB 2679d-GT: a novel factor IX variant with higher potency than factor IX Padua. Blood. 137(21). 2902–2906. 9 indexed citations
7.
Furfine, Eric S., et al.. (2019). Pegylated CB2782: a Complement Factor C3-Inactivating Protease and Potential Long-Acting Treatment for Dry AMD. Investigative Ophthalmology & Visual Science. 60(9). 374–374. 2 indexed citations
8.
Bloem, Esther, Ditte M. Karpf, Peder Lisby Nørby, et al.. (2018). Factor VIII with a 237 amino acid B‐domain has an extended half‐life in F8‐knockout mice. Journal of Thrombosis and Haemostasis. 17(2). 350–360. 4 indexed citations
9.
Mathiasen, Lisa, Daniel M. Dupont, Anni Christensen, et al.. (2008). A Peptide Accelerating the Conversion of Plasminogen Activator Inhibitor-1 to an Inactive Latent State. Molecular Pharmacology. 74(3). 641–653. 22 indexed citations
10.
Blouse, Grant E., et al.. (2008). A Novel Mode of Intervention with Serine Protease Activity. Journal of Biological Chemistry. 284(7). 4647–4657. 31 indexed citations
11.
Blouse, Grant E., et al.. (2008). A Deletion Mutant of Vitronectin Lacking the Somatomedin B Domain Exhibits Residual Plasminogen Activator Inhibitor-1-binding Activity. Journal of Biological Chemistry. 283(16). 10297–10309. 28 indexed citations
12.
Jensen, Jan K., et al.. (2008). Characterization of a Site on PAI-1 That Binds to Vitronectin Outside of the Somatomedin B Domain. Journal of Biological Chemistry. 283(42). 28487–28496. 28 indexed citations
13.
Dupont, Daniel M., Grant E. Blouse, Lisa Mathiasen, et al.. (2006). Evidence for a Pre-latent Form of the Serpin Plasminogen Activator Inhibitor-1 with a Detached β-Strand 1C. Journal of Biological Chemistry. 281(47). 36071–36081. 34 indexed citations
14.
Hansen, Martin, Troels Wind, Grant E. Blouse, et al.. (2005). A Urokinase-type Plasminogen Activator-inhibiting Cyclic Peptide with an Unusual P2 Residue and an Extended Protease Binding Surface Demonstrates New Modalities for Enzyme Inhibition. Journal of Biological Chemistry. 280(46). 38424–38437. 48 indexed citations
16.
Ibarra, Catherine, et al.. (2004). The Contribution of the Exosite Residues of Plasminogen Activator Inhibitor-1 to Proteinase Inhibition. Journal of Biological Chemistry. 279(5). 3643–3650. 35 indexed citations
17.
Perron, Michel, Grant E. Blouse, & Joseph D. Shore. (2003). Distortion of the Catalytic Domain of Tissue-type Plasminogen Activator by Plasminogen Activator Inhibitor-1 Coincides with the Formation of Stable Serpin-Proteinase Complexes. Journal of Biological Chemistry. 278(48). 48197–48203. 15 indexed citations
18.
Weinsheimer, Shantel, et al.. (2003). Structural Determinants of the Calpain Inhibitory Activity of Calpastatin Peptide B27-WT. Journal of Biological Chemistry. 278(10). 7800–7809. 45 indexed citations
19.
Blouse, Grant E., et al.. (2002). A Concerted Structural Transition in the Plasminogen Activator Inhibitor-1 Mechanism of Inhibition. Biochemistry. 41(40). 11997–12009. 16 indexed citations
20.
Blouse, Grant E., Guang Liu, & Richard H. Hilderman. (1998). Characterization of ATP and P2 agonists binding to the cardiac plasma membrane P1,P4-diadenosine 5′-tetraphosphate receptor. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1375(1-2). 61–72. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026